BRCA1 and pancreatic neoplasm: It has been reported that 25% of the patients with BRCA1/2 gene germline mutations are at risk of developing pancreatic cancer, and the lifetime risk of developing pancreatic cancer in patients with BRCA1/2 gene germline mutations is estimated to be 3–8% [39,40,41,42].